Current Diabetes Reviews

Joseph L. Evans, Ph.D., is Executive Manager, Research and Development, Stratum Nutrition (Saint Charles, MO, USA), and a Novus International Science Fellow. Dr. Evans holds a Ph.D. in Biochemistry from Drexel University, and received post-doctoral training in physiology and pharmacology at Dartmouth Medical School and the Panum Institute. Dr. Evans’ translational research experience extends from mechanistic research through randomized, controlled, clinical trials, and has successfully focused on the discovery and commercialization of pharmacological and nutritional interventions for the metabolic and cardiovascular diseases. Dr. Evans has published approximately 80 peer-reviewed scientific papers, review articles, book chapters, abstracts, and US patents.

Dr. Hoffman obtained his medical degree (M.D.) from The Ohio State University College of Medicine. He did his pediatric residency at the Akron Children’s Hospital and his pediatric endocrinology fellowship at Children’s Hospital of Pittsburgh. He is currently a Professor of Pediatrics and Program Director for the Pediatric Endocrinology Fellowship at Nationwide Children’s Hospital and The Ohio State University. His research interests are type 1 diabetes, hypoglycemia and the cardiovascular endocrinology.

Dr. David Wagner did B.S. (Magna cum Laude) in Chemistry and Biology from King College, Bristol, TN/VA in 1984. He did his M.S. in Biochemistry from East Tennessee State University, Johnson City, TN in 1987. Lastly Ph.D. in Biomedical Sciences from East Tennessee State University, Quillen College of Medicine Johnson City, TN in 1994. Since 2010, Dr. Wagner is an Associate Professor in the Dept. of Medicine and Head of Section of Immunology Webb-Waring Center at University of Colorado Denver. He has numerous contributions, honors, awards and publications to his credit.

Dr Gazzaruso is Head of the Diabetes and Endocrine-metabolic disease Unit, of the Emergency Unit and of the Center for Applied Clinical Research (Ce.R.C.A.) at Clinical Institute “Beato Matteo”, Vigevano, Italy of the Hospital Group San Donato. He is certified specialist and PhD in Internal Medicine and has a Master on type 2 diabetes. He was specialist and researcher at Maugeri Foundation, Pavia, Italy and consultant in Internal Medicine, Endocrinology and Cardiology at Mondino Foundation, Pavia, Italy. He has the National Scientific Qualification as an Associate Professor of Endocrinology. From 1997 he acts as a contract professor at the University of Pavia. He is authors of more than 90 peer-reviewed articles.

Prof. Anoop Misra is the Chairman, Fortis-CDOC Center of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, New Delhi, India and has been a faculty at the Department of Endocrinology at the Southwestern Medical Center in Dallas, Texas, USA, and All India Institute of Medical Sciences, New Delhi. He has lead consensus guidelines for obesity, the metabolic syndrome, physical activity, and diets for Asian Indians. His current research includes fatty liver and fatty pancreas in relation to insulin resistance and diabetes. He has been awarded highest award for medicine in India Dr BC Roy award (2006) and prestigious Indian National Honor, Padma Shree (2007).

Dr. Shanhu Qiu received his M.D. training in Ulm University, Ulm, Germany. He is currently an Associate Professor (Associate Research Fellow) in the Department of Endocrinology in Zhongda Hospital, Southeast University, Nanjing, China. Dr. Shanhu Qiu has published more than 30 scientific peer reviewed articles, and his research interest includes exercise and physical activity in type 2 diabetes, the epidemiology of type 2 diabetes, as well as the weight management for type 2 diabetes.

Dr. Yorek obtained a doctorate (Ph.D.) in Biochemistry from the University of North Dakota. Currently Dr. Yorek is a Professor in the Division of Endocrinology and Metabolism in the Department of Internal Medicine at the College of Medicine at the University of Iowa. He is also the Associate Chief of Staff at the Iowa City VA Medical Center. His research interest includes vascular and neural complications of obesity and diabetes. He has published more than 140 scientific peer reviewed publications.

Professor Ernest Adeghate obtained his medical degree from Semmelweis University Medical School, Budapest, Hungary and his PhD and DSc from the Hungarian Academy of Sciences. He also has a Master degree in Family Medicine from Monash University, Australia. He is interested in the morphology of pancreatic grafts and the effect of neurotransmitters, neuropeptides and cytokines on parameters of metabolic disease, insulin release and on complications of diabetes mellitus. Prof. Adeghate has published more than 200 peer-reviewed articles. He is currently, the Editor-in Chief of The Open Medicinal Chemistry Journal published by Bentham Science Publishers.

Specialist in Internal Medicine and Endocrinology, graduated from the Instituto Nacional de Ciencias Medicas y Nutricion. Doctor of Clinical Investigation. Research follow at the Washington University. School of Medicine. He has published 275 articles in indexed journals. Member of the Mexican National Academy of Medicine. Former president of the Mexican Society of Nutrition and Endocrinology (2009). His work has contributed to describe the epidemiology and genetics of type 2 diabetes and dyslipidemias in Mexicans.

Fabio Angeli is a Cardiologist and Biomedical researcher trained in cardiovascular medicine, particularly in the context of cardiovascular risk assessment, diabetes, kidney diseases, heart failure, acute coronary syndromes and maternal and neonatal healthcare. He has published more than 160 papers in reputed journals indexed by PubMed and has been serving as an editorial board member of several international leading Journals.

Dr. Bakhtiyari received his Ph.D. in Clinical Biochemistry from Tarbiat Modares University School of Medicine in Iran. He is currently an Associate Professor and Principal Investigator in Molecular Diabetology and Molecular sciences in the Department of Clinical Biochemistry and the Biotechnology and Medicinal Plants Research Center at Ilam University of Medical Sciences in Iran. His research focuses on Insulin signaling pathway in type 2 diabetes, Molecular mechanism of insulin resistance and type 2 diabetes, Gene expression analysis in Insulin resistance and type 2 diabetes, and Molecular mechanism of lipid-induced insulin resistance. He has published nearly 60 peer-reviewed papers in journals.

Dr. Lu Cai received his MD and a Ph.D. in Radiation Biology/Oncology from Jilin University (formally Norman Bethune University of Medical Sciences), Changchun, P.R. China. He also holds the appointment as Visiting Professor at Jilin University and Wenzhou Medical University. Dr. Cai is currently a tenured Professor, with appointments in the departments of Pediatrics, Radiation Oncology and Pharmacology, and Toxicology. Dr. Cai was also appointed as Director of Kosair Children’s Hospital Research Institute, the University of Louisville School of Medicine. He has published more than 210 in the field of diabetes and its complications. Currently, Dr. Cai serves as Associate Editor of Toxicological Science, and was Senior Editor for Journal of Geriatric Cardiology and Journal of Diabetes Research and Clinical Metabolism

Dr. Dandona is a Distinguished Professor of Medicine and chief of the Division of Endocrinology, Diabetes and Metabolism, at the University at Buffalo, The State University of New York, and the founder of the Diabetes–Endocrinology Center of Western New York in Buffalo. Dr. Dandona is a Rhodes Scholar from India, trained at the University of Oxford and the University of London. Dr. Dandona has published more than 540 papers in peer-reviewed medical journals, and has presented keynote lectures on diabetes and insulin resistance at many national and international conferences

Dr. Gu’s education background includes BSc in Animal Medicine (Nanjing, China 1982), MSc in Pathology (Nanjing, China 1988) and Ph.D. in Genetics (Uppsala, Sweden 1994). Currently, he is a Professor in Molecular Medicine and Director for Center of Pathophysiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. Before then, he is an Associate Professor and Senior Researcher in Molecular Genetics and Epigenetics, Karolinska Institutet, Stockholm, Sweden. His research interests are mainly focused on molecular medicine and translation medicine in diabetes, obesity and diabetic nephropathy. He has published over 150 peer-reviewed articles in international journals and chapters in five books related with diabetes and diabetic nephropathy. harvest.gu@ki.se

Dr. Hampe received her PhD at the Weizmann Institute of Science in Israel in 1997. She did her post-doctoral training in Dr. Åke Lernmark’s laboratory at the University of Washington, Seattle and is currently an Associate Professor at the Diabetes Research Institute at the University of Washington. She has 20 years of research experience focusing on autoimmune diseases including Type 1 diabetes and autoimmune neurological disorders. Dr. Hampe has authored over 100 manuscripts. She serves on study sections at the Juvenile Diabetes Research Foundation, the American Diabetes Association and NIH.

Dr. Kamoi obtained a doctorate (M.D.) on March 1970 in Medicine from theUniversity of Niigata, Japan. Dr. Kamoi also holed an research fellow in septeｍber 1977 to May to 1979 from the University of Indiana and Professor of Niigata University in April 2010 to March 2014. Currently, Dr. Kamoi is also an in the Director of Diabetes Mellitus & Disorders of hyothamic pituitary glands in Joetsu General Hospital, Japan. He has published more than 200 scientific publications .Dr. Kamoi was the editor of board members of Current Diabetes Review (2005) of this journal (Current Diabetes Review), published by Bentham Science Publishers.

Dr. ismail Laher is a Professor of Pharmacology and Therapeutics at the University of Pharmacology. He holds a degree in pharmacology from the University of London and graduate training in Canada and post-graduate training at the University of Vermont. Dr. Laher’s research interests are in vascular regulation (particularly of small arteries) in health and disease and the effects of exercise in improving endothelial function (e.g. in diabetes). More recent work focusses on the vascular function in rodent models of obstructive sleep apnea (especially in conjunction with underlying complications of diabetes / obesity).

Dr. Melpomeni Peppa is an Associate Professor of Endocrinology and Director of Endocrine and Bone Metabolic Disorders Unit of 2nd Propaedeutic Department of Internal Medicine & Research Institute, Attikon University Hospital in Athens, Greece. She is a member of the ERASMUS/CIVIS Committee for Medicine and Faculty Staff for the training of medical students in Internal Medicine. She had a postdoctoral Research fellowship (2000-2003) in Division of Experimental Diabetes and Aging, Department of Geriatrics, Mount Sinai School of Medicine, NY, USA, studying the role of advanced glycation end products and oxidative stress in diabetes, renal disease, aging, and their complications through in vitro, in vivo and clinical studies. Her research interests have focused on clinical, molecular and environmental aspects of metabolic and hormonal abnormalities in diabetes, obesity, metabolism, endocrine cancer and their complications. Her work has generated 75 publications in peer-reviewed journals. Also, Dr. Peppa has participated in many national and international conferences.

Demosthenes Panagiotakos is Professor and vice Rector at the Harokopio University in Athens. He is also visiting Distinguished Professor at School of Arts and Sciences, Rutgers, the State University of New Jersey, US, visiting Professor at the School of Medicine, University of Athens and at the Agricultural University of Athens. He has published 3 books, 600+ papers (has >13.500 citations, h-index=55). He is Member of the Scientific Committee of Health, Environment and Emerging Risks of the European Committee, the Scientific Council of the Hellenic Food Authority, the National Council for Nutrition Policy and has served as Board Member of the National Council of Public Health.

Professor Nikolaos Papanas is Professor in Internal Medicine-Diabetes Mellitus at Democritus University of Thrace, Greece. He has been specialised in diabetes and its complications in the Diabetes Centre and the Diabetic Foot Clinic at King’s College Hospital, London, UK, as well as in the German Diabetes Centre at the Heinrich Heine University, Düsseldorf, Germany. He has established an ongoing collaboration with the neuropathy study group of the German Diabetes Centre in Düsseldorf. He has published more than 290 papers in peer-reviewed journals.

Dr. Alisa Phulukdaree is presently serving as an Associate Professor at the University of Pretoria. She completed her B. Sc and M. Sc in Medical Biochemistry from the University KwaZulu-Natal. She further obtained PhD in the same field from the same institution in 2013. She is serving as an editor/reviewer in different scientific journals. She has also been recognized with awards and prizes such as Exceptional Young Researcher Award from University of Pretoria, Professional Providence Society Scholarship and National Research Foundation Doctoral Scholarship. She has also contributed her valuable publications in different scientific journals.

Born on 21 of August 1970 in Rome. Degree with top marks in medicine and surgery in 1995 from Catholic University of Rome and Specialized in Endocrinology and metabolism from 2000. Currently is Chief Director of Diabetes care Unit of Foundation Agostino Gemelli Hospital and Associate Professor of Endocrinology in the Catholic University of Rome Author of 146 papers with Hindex=33 (Scopus). His main field of interest are the treatment of type 1 and type 2 diabetes and its complications (in particular diabetic foot) and diabetes in pregnancy. He was one of the authors of Italian Reccomandations for the Utilization of Technology in Diabetes and He was one of the nn international task force of experts convened by the American Diabetes Association and the American Podiatric Medical Association to summarize available evidence on the pathophysiology, natural history, presentations, and treatment recommendations for Charcot Foot. dario.pitocco@policlinicogemelli.it

Dr. Giuseppe Seghieri graduated with cum laude in medicine from the University of Florence, Italy. He did specialization with cum laude in Medical Toxicology (1978), in Gastroenterology (1982), in Clinical Pharmacology (1986), in Internal Medicine (1992) and in Endocrinology (2007). Dr. Seghieri has been Chief of hospital department of internal medicine at the Hospital of Pistoia, Italy for more than 20 years. He is a research fellow at the Regional Health Agency of Tuscany, Florence, Italy and also professor of Internal Medicine at the University of Florence (Chair of Physiotherapy). He is (co-) author of more than 150 papers mostly dealing with diabetes and its complications, cardiovascular diseases or gender medicine.

Dr. Vijay Shivaswamy is an endocrinologist in Omaha, Nebraska and is affiliated with multiple hospitals in the area, including Nebraska Medicine-Nebraska Medical Centerand Veterans Affairs Nebraska-Western Iowa Health Care System-Lincoln. He received his medical degree from Bangalore Medical College and has been in practice between 11-20 years.

Dr. Nicola Troisi received his MD degree magna cum laude from the University “Federico II”, Naples, Italy. He attended the post-doctorate fellowship training at the University of Florence, Italy, and he obtained the title of Specialist in Vascular Surgery (magna cum laude with a final experimental study “New technical solutions for the endovascular treatment of aneurysms of abdominal aorta and of iliac arteries”). He was Clinical Research Fellow at the Department of Vascular Surgery, St. Franziskus Hospital, Münster, Germany and at the Department of Vascular and Endovascular Surgery, University Hospital, Münster, Germany. He authored and co-authored about 170 publications of which 82 published in peer-reviewed scientific journals.

Dr. Vinik is an international leader in basic and clinical neuropathy and neuroendocrine tumors, and isolated INGAP in clinical trials for “Curing” diabetes. He has authored ten books, 124 book chapters, and published more than 500 papers in highly reputable journals. Dr. Vinik received the Virginia Outstanding Scientist Award, was elected a Health Care Hero, received lifetime recognition for contributions to Neuropathy and a distinction in endocrinology. He has served NIH and ADA grant committees and funded by NIH, NIAA, ADA and industry. He holds patents for INGAP and copyrights for the Norfolk Quality of Life DN and NET tools.

Dr. Xu is currently an Assistant Professor and Principal Investigator of Protein-Ligand Interactions and Molecular Medicine Laboratory in the Department of Biochemistry and the Center for Drug Discovery at Virginia Tech in the US. He received his Ph.D. in Biochemistry from Case Western Reserve University School of Medicine in Cleveland, Ohio and did his postdoctoral fellowship at Fred Hutchinson Cancer Research Center in Seattle, Washington. His research focuses on discovery and mechanisms of novel peptide hormones and small molecules relevant to diabetes, obesity (adipocyte browning and thermogenesis agents) and related neurodegeneration. He has published nearly 40 peer-reviewed papers in journals.

Hanan Farouk Aly , PhD Thesis: "Study of some influential factors on adenylate energy charge and urea cycle enzymes in mice livers". (Faculty of science, biochemistry and physiology –Mansoura Univ. , Egypt 2000).M.Sc. Thesis: "studies of serum protein profile during liver regeneration after partial hepatectomy". (Faculty of Science, Biochemistry and Physiology – Mansoura Unv.,Egypt1997).

I received PhD degree in 2008 from Ankara University. I have been employed at Department of Pharmacology ( Ankara University) as Associate Professor . My main research interests are diabetes, cardiovascular / endocrine pharmacology and cardiac beta adrenoceptors.

Dr. Tapan Behl obtained his Ph.D. degree (in 2017) in Pharmacology from University of Delhi, New Delhi, India. Dr. Behl is currently an Associate Professor in the Department of Pharmacology at Chitkara College of Pharmacy, Chitkara University, Rajpura, India. His skills and expertise mainly lie in the subject areas/fields of Cell Signaling, Apoptosis, Antioxidant Activity, Reactive Oxygen Species, Oxidative Stress, Pathology, Diabetic Complications, etc. Dr. Behl, as an author/co-author, has published more than 15 articles in various journals of international repute.

I have a BSc degree in Biological Sciences from Mackenzie Presbyterian University and a MSc degree in Translational Medicine from the Federal University of São Paulo. I hold a PhD in Translational Medicine from Federal University of Sao Paulo and I am currently working as a post-doctoral scholar at University of Chicago. During my PhD program I worked as a Lab Tech Research at Rush University, in Chicago. I have great interest in studies related to obesity, diabetes, non-alcoholic fatty liver disease, liver-related studies and endocrinology studies. Lately, I have been studying the importance of Kruppel-like Zinc Fingers in the liver and its relationship with lipid metabolism. I have more than ten years of experience working in a lab environment as a researcher, and have published 13 peer-reviewed scientific papers and review articles.

Dr. Prasant Kumar Jena received his BSc in Biological Sciences and MSc in Biotechnology from Berhampur University. Later, he obtained a Ph.D. in Biotechnology from Nirma University (India). He has more than 9 years of research experience in studying the impact of diet and gut microbiota on the development of metabolic diseases including obesity, diabetes, and carcinogenesis. In his graduate studies, he developed a sugar diet-induced diabetes rat model to study the effect of microbiota and probiotic intervention in lipid and carbohydrate metabolism. Currently, Dr. Jena is working at University of California Davis as a researcher.

Dr Pranav Kumar Prabhakar has received his PhD in Biotechnology from Indian Institute of Technology (IIT) Madras, India during the period of 2011 and he has completed his master in biochemistry from Patna University Bihar, India in 2003. Currently, he is working as Assistant Professor in Lovely Professional University Punjab, India. He has successfully completed his Administrative responsibilities as research coordinator of the school. His research has included synergy, Phytomedicine, metabolic disorders. He is serving as an editorial member of several reputed journals and expert Reviewers for many journals. He has authored 35+ research articles/books/ book chapters. He is a member of Royal Society of Chemistry and Asia-Pacific Chemical, Biological & Environmental Engineering Society (APCBEES).

Dr. Ravi Kant obtained fellowship in diabetes from CMC Vellore and from Harvard University, where he is a course director for the certificate course in diabetes in India. Currently, he is serving as an Additional Professor and head at the division of diabetes and metabolism in the department of medicine at All India Institute of Medical Sciences, Rishikesh. Dr. Kant was the one to develop the department of medicine at AIIMS Rishikesh. He is also currently the secretary for South East Asian Foundation and the editor of South East Asian Medical Clinics. He is international advisor to the journal of diabetes and endocrine society of Nepal and also journal of public health and holistic medicine.